nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accurate, rapid, point-of-care tests for sexually transmitted infections
|
Unemo, Magnus |
|
|
21 |
5 |
p. 584-586 |
artikel |
2 |
A legacy of disease
|
Gröschel, Matthias I |
|
|
21 |
5 |
p. 614 |
artikel |
3 |
Alternatives to conventional hospitalisation that enhance health systems' capacity to treat COVID-19
|
Nicolás, David |
|
|
21 |
5 |
p. 591-593 |
artikel |
4 |
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial
|
Van Dijck, Christophe |
|
|
21 |
5 |
p. 657-667 |
artikel |
5 |
Antibiotic overuse in China: call for consolidated efforts to develop antibiotic stewardship programmes
|
Walley, John D |
|
|
21 |
5 |
p. 597 |
artikel |
6 |
Antiseptic mouthwashes against sexually transmitted infections
|
de Vries, Henry J C |
|
|
21 |
5 |
p. 583-584 |
artikel |
7 |
Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trial
|
Chow, Eric P F |
|
|
21 |
5 |
p. 647-656 |
artikel |
8 |
Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses
|
Zaid, Ali |
|
|
21 |
5 |
p. e123-e133 |
artikel |
9 |
Associations between phone mobility data and COVID-19 cases
|
Gatalo, Oliver |
|
|
21 |
5 |
p. e111 |
artikel |
10 |
A year and a day of #Covid19uk tweets
|
Mackenzie, Graham |
|
|
21 |
5 |
p. 616 |
artikel |
11 |
Beyond COVID-19—a paradigm shift in infection management?
|
Vehreschild, Maria J G T |
|
|
21 |
5 |
p. e117 |
artikel |
12 |
Bilateral infiltrates in a health-care worker during the COVID-19 pandemic
|
Schindler, Otmar |
|
|
21 |
5 |
p. 742 |
artikel |
13 |
CEPI prepares for future pandemics and epidemics
|
Samarasekera, Udani |
|
|
21 |
5 |
p. 608 |
artikel |
14 |
Change in obstetric attendance and activities during the COVID-19 pandemic
|
Khalil, Asma |
|
|
21 |
5 |
p. e115 |
artikel |
15 |
Community transmission of rotavirus infection in a vaccinated population in Blantyre, Malawi: a prospective household cohort study
|
Bennett, Aisleen |
|
|
21 |
5 |
p. 731-740 |
artikel |
16 |
Congenital malformations in sub-Saharan Africa—warnings of a silent epidemic?
|
Sié, Ali |
|
|
21 |
5 |
p. 594-596 |
artikel |
17 |
Correction to Lancet Infect Dis 2021; 21: 697–710
|
|
|
|
21 |
5 |
p. e122 |
artikel |
18 |
Correction to Lancet Infect Dis 2021; 21: 677–87
|
|
|
|
21 |
5 |
p. e122 |
artikel |
19 |
Correction to Lancet Infect Dis 2021; published online Jan 29. https://doi.org/10.1016/S1473-3099(20)30692-7
|
|
|
|
21 |
5 |
p. e122 |
artikel |
20 |
Correction to Lancet Infect Dis 2020; published online March 25. https://doi.org/10.1016/S1473-3099(21)00151-1
|
|
|
|
21 |
5 |
p. e122 |
artikel |
21 |
COVID-19: the deadly threat of misinformation
|
Galvão, Jane |
|
|
21 |
5 |
p. e114 |
artikel |
22 |
CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants
|
Alam, Intikhab |
|
|
21 |
5 |
p. 602 |
artikel |
23 |
CROI 2021
|
Kazi, Farooq |
|
|
21 |
5 |
p. 606 |
artikel |
24 |
Defining the diagnosis of cryptosporidiosis
|
Chalmers, Rachel M |
|
|
21 |
5 |
p. 589-590 |
artikel |
25 |
Disseminated gonococcal infection in a patient with paroxysmal nocturnal haemoglobinuria receiving eculizumab
|
Niitsuma-Sugaya, Ikumi |
|
|
21 |
5 |
p. 741 |
artikel |
26 |
Dog's own country
|
Balakrishnan, Vijay Shankar |
|
|
21 |
5 |
p. 615 |
artikel |
27 |
Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study
|
Babiker, Ahmed |
|
|
21 |
5 |
p. 697-710 |
artikel |
28 |
Effectiveness of rotavirus vaccine in preventing transmission of rotavirus from children to household contacts in Malawi
|
Mwenyenkulu, Tisungane Edward |
|
|
21 |
5 |
p. 590-591 |
artikel |
29 |
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
|
Nazemipour, Maryam |
|
|
21 |
5 |
p. 603-604 |
artikel |
30 |
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
|
Ghafari, Mahan |
|
|
21 |
5 |
p. 602-603 |
artikel |
31 |
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
|
Darvishian, Maryam |
|
|
21 |
5 |
p. 604-605 |
artikel |
32 |
Faecal microbiota transplantation: more screening for old and new pathogens
|
Hohmann, Elizabeth L |
|
|
21 |
5 |
p. 587-589 |
artikel |
33 |
First immunogenicity data for the UK serogroup B meningococcal vaccination schedule in infants
|
McNamara, Lucy A |
|
|
21 |
5 |
p. 586-587 |
artikel |
34 |
Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study
|
Li, Fang |
|
|
21 |
5 |
p. 617-628 |
artikel |
35 |
Hydroxychloroquine and COVID-19: a tale of populism and obscurantism
|
Peiffer-Smadja, Nathan |
|
|
21 |
5 |
p. e121 |
artikel |
36 |
Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
|
Van Elslande, Jan |
|
|
21 |
5 |
p. e120 |
artikel |
37 |
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial
|
Davis, Kimberly |
|
|
21 |
5 |
p. 688-696 |
artikel |
38 |
“In an ocean of ashes, islands of order”: WHO's SARS-CoV-2 origin report
|
The Lancet Infectious Diseases, |
|
|
21 |
5 |
p. 579 |
artikel |
39 |
Infectious diseases in Yemen
|
Burki, Talha |
|
|
21 |
5 |
p. 610-611 |
artikel |
40 |
Infectious disease surveillance update
|
Zwizwai, Ruth |
|
|
21 |
5 |
p. 611 |
artikel |
41 |
Intention to vaccinate against COVID-19 in Australia
|
Rhodes, Anthea |
|
|
21 |
5 |
p. e110 |
artikel |
42 |
Journey to Wuhan during its lockdown
|
Burki, Talha |
|
|
21 |
5 |
p. 613 |
artikel |
43 |
Limitations of using mobile phone data to model COVID-19 transmission in the USA
|
Badr, Hamada S |
|
|
21 |
5 |
p. e113 |
artikel |
44 |
Long COVID: tackling a multifaceted condition requires a multidisciplinary approach
|
Norton, Alice |
|
|
21 |
5 |
p. 601-602 |
artikel |
45 |
Low risk of SARS-CoV-2 transmission by fomites in real-life conditions
|
Mondelli, Mario U |
|
|
21 |
5 |
p. e112 |
artikel |
46 |
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results
|
MacLennan, Jenny M |
|
|
21 |
5 |
p. 677-687 |
artikel |
47 |
MIS-C: post-infectious syndrome or persistent infection?
|
Schwartz, Michael |
|
|
21 |
5 |
p. e116 |
artikel |
48 |
Optimism and caution for an inactivated COVID-19 vaccine
|
Rostad, Christina A |
|
|
21 |
5 |
p. 581-582 |
artikel |
49 |
Performance and operational feasibility of two diagnostic tests for cryptosporidiosis in children (CRYPTO-POC): a clinical, prospective, diagnostic accuracy study
|
Johansen, Øystein H |
|
|
21 |
5 |
p. 722-730 |
artikel |
50 |
Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study
|
Morris, Sheldon R |
|
|
21 |
5 |
p. 668-676 |
artikel |
51 |
Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study
|
Vendrik, Karuna E W |
|
|
21 |
5 |
p. 711-721 |
artikel |
52 |
Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode
|
Mohapatra, Prasanta Raghab |
|
|
21 |
5 |
p. 599-600 |
artikel |
53 |
Research in brief
|
Devi, Sharmila |
|
|
21 |
5 |
p. 612 |
artikel |
54 |
Rotavirus vaccine for children facing humanitarian crisis
|
Bagcchi, Sanjeet |
|
|
21 |
5 |
p. 609 |
artikel |
55 |
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
|
Ella, Raches |
|
|
21 |
5 |
p. 637-646 |
artikel |
56 |
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
|
Stringhini, Silvia |
|
|
21 |
5 |
p. 600-601 |
artikel |
57 |
Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
|
Choy, Kay Weng |
|
|
21 |
5 |
p. e118 |
artikel |
58 |
Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
|
Iversen, Kasper |
|
|
21 |
5 |
p. e119 |
artikel |
59 |
Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
|
Pallett, Scott J C |
|
|
21 |
5 |
p. 598-599 |
artikel |
60 |
1st Women in Malaria conference
|
Barksby, Rebecca |
|
|
21 |
5 |
p. 607 |
artikel |
61 |
Technical assessment of the neonatal early-onset sepsis risk calculator
|
Benitz, William E |
|
|
21 |
5 |
p. e134-e140 |
artikel |
62 |
The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada
|
Maharaj, Arjuna S |
|
|
21 |
5 |
p. 593-594 |
artikel |
63 |
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study
|
Marks, Michael |
|
|
21 |
5 |
p. 629-636 |
artikel |
64 |
Understanding the drivers of transmission of SARS-CoV-2
|
Cornelissen, Laura |
|
|
21 |
5 |
p. 580-581 |
artikel |
65 |
Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens
|
Choby, Jacob E |
|
|
21 |
5 |
p. 597-598 |
artikel |